Kathleen Borthwick
Finanzdirektor/CFO bei PASSAGE BIO, INC.
Vermögen: 34 729 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Kathleen Borthwick
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 25 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kathleen Borthwick
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Pennsylvania | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| SHIRE | Pharmaceuticals: Major | Public Communications Contact General Counsel | |
| University of Michigan | College/University | Masters Business Admin Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Chairman Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Masters Business Admin | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree | |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company that develops targeted in vivo RNA technologies to multiply therapeutic possibilities for patients. Capstan Therapeutics is based in San Diego, CA. The company's platform technology, tLNPs, delivers payloads capable of reprogramming specific cell types in vivo, including gene editing tools. The company aims to generate transformative therapies for autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. The company was founded in 2022 by Haig Aghajanian, and the CEO is Laura K. Shawver. | Miscellaneous Commercial Services | Chairman | |
NuMedii, Inc.
 NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| TURG POIN | Pharmaceuticals: Major | Chief Executive Officer | |
| CARDIFF ONCOLOGY, INC. | Medical Specialties | Director/Board Member | |
Avenzo Therapeutics, Inc.
 Avenzo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avenzo Therapeutics, Inc. is a biotechnology company that operates in the field of therapeutics. The company is based in San Diego, CA. The company was founded by Mohammad Hirmand and the CEO is Athena M. Countouriotis. | Miscellaneous Commercial Services | Chief Executive Officer | |
| UCLA Anderson School of Management | College/University | Masters Business Admin | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member | |
Leal Therapeutics, Inc.
 Leal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Leal Therapeutics, Inc. develops novel therapeutics for patients with major disorders of the central nervous systems. | Miscellaneous Commercial Services | Director/Board Member | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Public Communications Contact | |
Palm Beach Civic Association
 Palm Beach Civic Association Miscellaneous Commercial ServicesCommercial Services The Palm Beach Civic Association is an organization that advocates for the town of Palm Beach. The non-profit company is based in Palm Beach, FL. The company produces news and events for all residents on the island and aim to protect and improve the quality of life in the town by taking proactive stands on civic affairs. The company was founded in 1944. Robert C. Wright has been the CEO of the company since 2010. | Miscellaneous Commercial Services | Director/Board Member | |
| TRIUMPH GROUP, INC. | Aerospace & Defense | Human Resources Officer | |
| Shippensburg University of Pennsylvania | College/University | Undergraduate Degree | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Montclair State University | College/University | Undergraduate Degree | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
Novartis Pharmaceuticals UK Ltd.
 Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Novartis Pharmaceuticals AG | Corporate Officer/Principal | ||
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Tufts University School of Medicine | College/University | Doctorate Degree | |
| MORGAN STANLEY | Investment Managers | Corporate Officer/Principal | |
| Colgate University | College/University | Undergraduate Degree | |
GPC Biotech, Inc.
 GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Drugstore Chains | Sales & Marketing | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
Civetta Therapeutics LLC
 Civetta Therapeutics LLC Pharmaceuticals: MajorHealth Technology Civetta Therapeutics LLC develops therapeutics for cancers and other diseases. The company was founded by William Sellers and Eric Fischer and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
Deerfield Management Co. LP
 Deerfield Management Co. LP Investment ManagersFinance Deerfield Management Co. LP (Deerfield) is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Peter Drake in 1994. They are wholly owned by James E. Flynn and are controlled by its general partner, Flynn Management LLC. Deerfield provides discretionary investment management services in the healthcare sector to domestic and offshore private pooled investment vehicles and their related alternative investment vehicles. | Investment Managers | Corporate Officer/Principal | |
Credit Suisse Asset Management LLC
 Credit Suisse Asset Management LLC Investment ManagersFinance Founded in 1999, Credit Suisse Asset Management LLC (CSAM) is a registered investment advisor headquartered in New York City. The firm is an indirect wholly-owned subsidiary of Credit Suisse Group AG (NYSE: CS), a publicly owned foreign bank holding company based in Switzerland. | Investment Managers | Corporate Officer/Principal | |
| McGill University | College/University | Undergraduate Degree | |
| Columbia Law School | College/University | Graduate Degree | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 42 |
| Schweiz | 4 |
| Irland | 3 |
| Vereinigtes Königreich | 3 |
| Frankreich | 2 |
Sektoral
| Health Technology | 23 |
| Consumer Services | 15 |
| Commercial Services | 8 |
| Finance | 5 |
| Electronic Technology | 2 |
Operativ
| Director/Board Member | 110 |
| Corporate Officer/Principal | 53 |
| Independent Dir/Board Member | 44 |
| Chief Tech/Sci/R&D Officer | 30 |
| Undergraduate Degree | 17 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Thomas Woiwode | 39 |
| Liam Ratcliffe | 32 |
| Maxine Gowen | 23 |
| Eliseo Salinas | 22 |
| Sandipkumar S. Kapadia | 19 |
| Athena Countouriotis | 17 |
| Saqib Islam | 15 |
| Michael Kamarck | 15 |
| Derrell Porter | 14 |
| Jill Quigley | 11 |
| Bruce Goldsmith | 10 |
| Alex Fotopoulos | 7 |
| Desiree Luthman | 7 |
| James M. Wilson | 6 |
| Simona King | 6 |
- Börse
- Insiders
- Kathleen Borthwick
- Unternehmensverbindungen
